PRRT Market Forecast 2024–2034 Growth Trends
Market Overview The Peptide Receptor Radionuclide Therapy Market is entering a transformative decade, reflecting the rapid evolution of precision oncology. Valued at approximately USD 3.8 billion in 2024, the market is projected to surge to nearly USD 48.8 billion by 2034, expanding at an impressive CAGR of 29.1%. This remarkable growth trajectory underscores the rising clinical acceptance and...
0 Комментарии 0 Поделились 92 Просмотры 0 предпросмотр
Спонсоры